載入...
Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review
Schizophrenia (SCZ) is a severe mental disorder with high morbidity and lifetime disability rates. Patients with SCZ have a higher risk of developing metabolic comorbidities such as obesity and diabetes mellitus, leading to increased mortality. Antipsychotics (APs), which are the mainstay in the tre...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
SAGE Publishing
2022-05-01
|
叢編: | Therapeutic Advances in Psychopharmacology |
在線閱讀: | https://doi.org/10.1177/20451253221096525 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|